All news from Anaesthesiology

Brachytherapy is in Decline, and Money may be Why

The evidence is clear: Cervical cancer is best treated with brachytherapy, a form of radiation therapy. Yet the use of this potentially lifesaving treatment has been declining, and a new study published in International Journal of Radiation Oncology may explain why.  The study determined that eventhough, Medicare costs hospitals more than twice as much to provide brachytherapy as it does to provide external-beam radiation, the reimbursement doesn't reflect that.

A Rejected Antibiotic Candidate worth a Second Look

The drug, called pentyl pantothenamide , is able to stop the growth of  E.coli  but not completely kill the bacterium, so it was never taken into clinical use.The study findings were published in the journal  Biochemistry , open up the possibility of designing new drugs that use the same means to attack  E. coli,  but in a more effective way.

New Skin Patch may Help Reduce Body Fat

A new approach, published in the journal Small Methods, to reducing bulging tummy fats has shown promise in laboratory trials. The discovery could help to address the worldwide obesity problem without resorting to surgical operations or oral medication which could require large dosages and could have serious side effects.

A Cluster of Mutations in Neurofibromatosis

Ludwine Messiaen led the research at the University of Alabama at Birmingham, shows that missense mutations in a cluster of just five codons in the NF1 gene are an important risk factor for severe symptoms of the genetic disease neurofibromatosis type 1.The study was published in the American Journal of Human Genetics . It shows a potential need for increased disease surveillance of patients with missense mutations in that cluster.

Scientist Discover a New Ally for Tuberculosis

A new study published in the journal Angewandte Chemie International Edition represents a breakthrough for patients with tuberculosis. In search of new strategies against life-threatening tuberculosis infections, scientists have discovered a substance that interferes with the mycomembrane formation of the bacterium. It is effective in low concentrations and combined with antibiotics their effectiveness is improved by up to 100-fold.